CMRA - Looking for 5%Looking to take an entry if the technical patterns line up. I will either enter during the low to mid $4 zone or will wait for confirmation that breaks and closes above $5. This will either be a play for 5% or will be a scaling tactic to see how far it can go. (Not financial advice)
Key stats
Market capitalization
20.742MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.3840USD
About Comera Life Sciences Holdings, Inc
ISIN
US20037C1080
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
comeralifesciences.com
CEO
Jeffrey S Hackman
Headquarters
Woburn
Employees
13
Founded
2022
Comera Life Sciences Holdings, Inc. engages in developing medicines. It applies a deep knowledge of formulation science and technology to transform essential biologic medicines. The firm's approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen. The company was founded on January 31, 2022 and is headquartered in Woburn, MA.
$CMRA entry PTs 2.25-3 Long term PT 30 and higherComera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneo
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0